Stocktoria
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB
Nasdaq · XNAS · stock · Laboratory Analytical Instruments · website · IPO 2010-10-27
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 28.6% | 24.2% | 26.3% | 38.2% | 45.1% |
| Operating margin | -346.2% | -308.0% | -166.8% | -239.4% | -161.2% |
| Net margin | -341.5% | -201.2% | -153.0% | -244.9% | -138.9% |
| FCF margin | -71.2% | -137.8% | -133.7% | -218.2% | -89.7% |
| Return on assets | -69.7% | -24.6% | -17.6% | -17.8% | -9.0% |
| Return on equity | -10214.5% | -61.2% | -43.7% | -55.8% | -22.9% |
| Debt / equity | — | — | — | 1.59× | 1.13× |
| Current ratio | 5.15 | 7.48 | 7.81 | 3.24 | 15.36 |
| Revenue growth | 3.9% | -23.2% | 56.3% | -1.7% | 65.4% |
Source: SEC EDGAR filings · CIK 0001299130 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.